Spectral Medical Inc. EDT
Free
No email, no account, no signup.
General analysis — not personal advice.
Bull
Bear
Want to follow Spectral Medical Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Exchange
TSX
Type
Biotech
Sector
Medical Technology / Theranostics
Price & valuation
Last close
CAD 1.39
1 week
-0.7 %
3 months
-1.4 %
12 months
+27.5 %
From 52w high
-20.6 %
From 52w low
+69.5 %
We're already tracking Spectral Medical Inc. — here are the latest events we've registered
Recent News
- On August 7, 2026, Spectral reported its second-quarter 2026 financial results and provided a corporate update following the U.S. FDA's formal acceptance of its Premarket Approval application for PMX for substantive review. The submission was supported by positive 12-month follow-up data from the Phase III Tigris trial, which demonstrated sustained survival benefits.
What Firelda Watch includes for Spectral Medical Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — AI roundup of the week's news
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Spectral Medical Inc. will be delivered in the same format.
Want to follow Spectral Medical Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.